Improving Validation Practices in "Omics" Research

被引：169
作者：
Ioannidis, John P. A. [3 ,4 ,5 ]
Khoury, Muin J. [1 ,2 ]
机构：
[1] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA
[2] NCI, Div Canc Control & Populat Sci, NIH, Rockville, MD 20852 USA
[3] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA
来源：
SCIENCE | 2011年 / 334卷 / 6060期
关键词：
BIOINFORMATICS; PROTEOMICS;
D O I：
10.1126/science.1211811
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
"Omics" research poses acute challenges regarding how to enhance validation practices and eventually the utility of this rich information. Several strategies may be useful, including routine replication, public data and protocol availability, funding incentives, reproducibility rewards or penalties, and targeted repeatability checks.
引用
收藏
页码：1230 / 1232
页数：3
相关论文
共 21 条
  • [1] Public Availability of Published Research Data in High-Impact Journals
    Alsheikh-Ali, Alawi A.
    Qureshi, Waqas
    Al-Mallah, Mouaz H.
    Ioannidis, John P. A.
    [J]. PLOS ONE, 2011, 6 (09):
  • [2] Biomarker studies: a call for a comprehensive biomarker study registry
    Andre, Fabrice
    McShane, Lisa M.
    Michiels, Stefan
    Ransohoff, David F.
    Altman, Douglas G.
    Reis-Filho, Jorge S.
    Hayes, Daniel F.
    Pusztai, Lajos
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (03) : 171 - 176
  • [3] Disclose all data in publications
    Baggerly, Keith
    [J]. NATURE, 2010, 467 (7314) : 401 - 401
  • [4] DERIVING CHEMOSENSITIVITY FROM CELL LINES: FORENSIC BIOINFORMATICS AND REPRODUCIBLE RESEARCH IN HIGH-THROUGHPUT BIOLOGY
    Baggerly, Keith A.
    Coombes, Kevin R.
    [J]. ANNALS OF APPLIED STATISTICS, 2009, 3 (04) : 1309 - 1334
  • [5] Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]
  • [6] Clinical application of the 70-gene profile: The MINDACT trial
    Cardoso, Fatima
    Van't Veer, Laura
    Rutgers, Emiel
    Loi, Sherene
    Mook, Stella
    Piccart-Gebhart, Martine J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) : 729 - 735
  • [7] An empirical assessment of validation practices for molecular classifiers
    Castaldi, Peter J.
    Dahabreh, Issa J.
    Ioannidis, John P. A.
    [J]. BRIEFINGS IN BIOINFORMATICS, 2011, 12 (03) : 189 - 202
  • [8] Replicating genotype-phenotype associations
    Chanock, Stephen J.
    Manolio, Teri
    Boehnke, Michael
    Boerwinkle, Eric
    Hunter, David J.
    Thomas, Gilles
    Hirschhorn, Joel N.
    Abecasis, Goncalo
    Altshuler, David
    Bailey-Wilson, Joan E.
    Brooks, Lisa D.
    Cardon, Lon R.
    Daly, Mark
    Donnelly, Peter
    Fraumeni, Joseph F., Jr.
    Freimer, Nelson B.
    Gerhard, Daniela S.
    Gunter, Chris
    Guttmacher, Alan E.
    Guyer, Mark S.
    Harris, Emily L.
    Hoh, Josephine
    Hoover, Robert
    Kong, C. Augustine
    Merikangas, Kathleen R.
    Morton, Cynthia C.
    Palmer, Lyle J.
    Phimister, Elizabeth G.
    Rice, John P.
    Roberts, Jerry
    Rotimi, Charles
    Tucker, Margaret A.
    Vogan, Kyle J.
    Wacholder, Sholom
    Wijsman, Ellen M.
    Winn, Deborah M.
    Collins, Francis S.
    [J]. NATURE, 2007, 447 (7145) : 655 - 660
  • [9] Dupuy A., 2007, J NATL CANCER I, V17, P99
  • [10] Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
    Ioannidis, John P. A.
    Panagiotou, Orestis A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (21): : 2200 - 2210
123